Elevance Health (ELV) came out with quarterly earnings of $10.64 per share, beating the Zacks Consensus Estimate of $10.54 per share. This compares to earnings of $9.46 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 0.95%. A quarter ago, it was expected that this health insurer would post earnings of $5.55 per share when it actually produced earnings of $5.62, delivering a surprise of 1.26%.Over the last four quarters, the co ...

Exhibit 99.1 EARNINGS RELEASE ELEVANCE HEALTH REPORTS FIRST QUARTER 2024 RESULTS • 1Q 2024 operating revenue of $42.3 billion, up 0.9% from 1Q 2023 • 1Q 2024 diluted EPS1 of $9.59, up 15.5% from 1Q 2023 and adjusted diluted EPS2 of $10.64, up 12.5% • FY 2024 diluted EPS and adjusted diluted EPS guidance raised to greater than $34.05 and $37.20, respectively • Launching strategic partnership to advance primary care and physician enablement Indianapolis, IN—April 18, 2024—Elevance Health, Inc. (NYSE: ELV) rep ...

Investors are always looking for stocks that are poised to beat at earnings season and Elevance Health, Inc. (ELV) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Elevance is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good ...

Elevance Health Inc. (ELV) inked an agreement with the private investment firm, Clayton, Dubilier & Rice (“CD&R”). The partnership aims to launch an enhanced primary care offering across several U.S. regions by incorporating specific care delivery and enablement assets from three care providers, ELV’s Carelon Health and two portfolio companies of CD&R, apree health and Millennium Physician Group (“MPG”). Elevance Health’s investment in the recently announced tie-up will be a blend of cash and its stake in c ...

Elevance Health, Inc. (ELV) is set to beat on earnings for the first quarter of 2024, the results for which are scheduled to be released on Apr 18, before the opening bell.What Do the Estimates Say?The Zacks Consensus Estimate for first-quarter earnings per share of $10.52 suggests an 11.2% increase from the prior-year figure of $9.46. The consensus mark remained stable over the past week. The consensus estimate for first-quarter revenues of $42.4 billion indicates a 1.2% increase from the year-ago reported ...

Elevance Health (ELV) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 18 ...

Elevance Health Inc.’s (ELV) brand, Anthem Blue Cross and Blue Shield, recently entered into a multi-year deal with the Georgia-based integrated healthcare system, Piedmont. The agreement, effective from the very beginning of April 2024, serves as a sign of the continued collaboration between the ELV brand and Piedmont. This, in turn, is expected to equip the partners in continuing to offer high quality care services to the mutually served 400,000-plus members residing across metro Atlanta, Athens, Augusta, ...

Investors interested in Medical Services stocks are likely familiar with Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Elevance Health (ELV) , which belongs to the Zacks Medical Services industry.When looking at the last two reports, this health insurer has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 3.83%, on average, in the last two quarters.For the most recent quarter, Elevance Health was expected to post earnings of $5.55 ...

U.S. stock markets have been witnessing an astonishing rally in the past 15 months. However, the major driver of this rally was globally booming artificial intelligence (AI), especially generative AI. Companies that have extensive applications of AI in their final products have become multi-baggers in the past 15 months. Stock prices of some of these companies have skyrocketed 200-300% during this period.These highly overvalued stocks make a large section of financial researchers and analysts skeptical of i ...